162 related articles for article (PubMed ID: 19356087)
1. Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS.
Bajrami B; Krishnan S; Rusling JF
Drug Metab Lett; 2008 Aug; 2(3):158-62. PubMed ID: 19356087
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
3. [Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro].
Bi YF; Liu S; Zhang RX; Song FR; Liu ZQ
Yao Xue Xue Bao; 2013 Dec; 48(12):1823-8. PubMed ID: 24689241
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes.
Zangar RC; Benson JM; Burnett VL; Springer DL
Chem Biol Interact; 2000 Mar; 125(3):233-43. PubMed ID: 10731522
[TBL] [Abstract][Full Text] [Related]
6. Bioactivation to free radicals and cytotoxicity of 1,1-dichloro-1-fluoroethane (HCFC-141b).
Zanovello A; Tolando R; Ferrara R; Bortolato S; Manno M
Xenobiotica; 2001 Feb; 31(2):99-112. PubMed ID: 11407538
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the metabolism of ketoconazole using accurate mass.
Fitch WL; Tran T; Young M; Liu L; Chen Y
Drug Metab Lett; 2009 Aug; 3(3):191-8. PubMed ID: 19799546
[TBL] [Abstract][Full Text] [Related]
8. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
[TBL] [Abstract][Full Text] [Related]
9. Rapid LC-MS drug metabolite profiling using microsomal enzyme bioreactors in a parallel processing format.
Bajrami B; Zhao L; Schenkman JB; Rusling JF
Anal Chem; 2009 Dec; 81(24):9921-9. PubMed ID: 19904994
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes.
Liu L; Sun S; Rui H; Li X
Pharm Biol; 2017 Dec; 55(1):1868-1874. PubMed ID: 28614988
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent.
Östlund J; Zlabek V; Zamaratskaia G
Toxicology; 2017 Apr; 381():10-18. PubMed ID: 28232125
[TBL] [Abstract][Full Text] [Related]
12. CYPs-mediated drug-drug interactions on psoralidin, isobavachalcone, neobavaisoflavone and daidzein in rats liver microsomes.
Shi M; Cui Y; Liu C; Li C; Liu Z; Kang WY
Food Chem Toxicol; 2020 Feb; 136():111027. PubMed ID: 31870919
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
Shaik AN; LeDuc BW; Khan AA
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with turmeric modulates the inhibitory influence of cisplatin and paclitaxel on CYP2E1 and CYP3A1/2 in isolated rat hepatic microsomes.
Ahmed EM; EL-Maraghy SA; Teleb ZA; Shaheen AA
Chem Biol Interact; 2014 Sep; 220():25-32. PubMed ID: 24882083
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 metabolism of styrene involves allostery.
Hartman JH; Boysen G; Miller GP
Drug Metab Dispos; 2012 Oct; 40(10):1976-83. PubMed ID: 22807108
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine.
Lin HL; Roberts ES; Hollenberg PF
Carcinogenesis; 1998 Feb; 19(2):321-9. PubMed ID: 9498284
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
18. Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1
Zhang G; Zhang Y; Ma X; Yang X; Cai Y; Yin W
Pharm Biol; 2021 Dec; 59(1):532-536. PubMed ID: 33915070
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity.
Li WL; Xin HW; Su MW; Xiong L
Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):163-9. PubMed ID: 20448858
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
